| abstract |
Compounds represented by Formula (I): or pharmaceutically acceptable salts thereof are glycogen phosphorylase inhibitors and are useful in the prophylactic or therapeutic treatment of diabetes, hyperglycemia, hypercholesterolemia, hyperinsulinemia, hyperlipidemia, hypertension, atherosclerosis, or tissue ischemia , for example myocardial ischemia, and in the form of cardioprotectors. |